SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001385508-19-000051
Filing Date
2019-05-09
Accepted
2019-05-09 16:13:00
Documents
4
Period of Report
2019-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8k_earningsreleasex5x9x19.htm 8-K 27222
2 EXHIBIT 99.1 a2019-05x09_opntx1q19xfina.htm EX-99.1 25904
3 a20190509opnt1q19fina_image1.gif GRAPHIC 144989
4 a20190509opnt1q19fina_image2.gif GRAPHIC 123119
  Complete submission text file 0001385508-19-000051.txt   424102
Mailing Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401
Business Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38193 | Film No.: 19810666
SIC: 1000 Metal Mining